Real-Time Tumor-Tracking Radiotherapy and General Stereotactic Body Radiotherapy for Adrenal Metastasis in Patients With Oligometastasis

Overview of attention for article published in Technology in Cancer Research & Treatment, November 2018

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
Among the highest-scoring outputs from this source (#43 of 1,906)
High Attention Score compared to outputs of the same age (83rd percentile)
High Attention Score compared to outputs of the same age and source (93rd percentile)

Mentioned by

policy: 1 policy source
twitter: 2 X users

facebook: 1 Facebook page
guideline: 2 clinical guideline sources

Readers on

mendeley: 28 Mendeley

So far, Altmetric has seen 1 policy document that references this research output.

Stereotactic Ablative Radiotherapy for the Treatment of Oligometastatic Cancer - Stereotactic Ablative Radiotherapy for the Treatment of Oligometastatic Cancer: A Clinical Review as Part of a Health Technology Assessment, Version 2.0

Cited by Canadian Agency for Drugs and Technologies in Health (CADTH) on 20 Jun 2022

CADTH is an independent, not-for-profit organization responsible for providing health care decision-makers with objective evidence to help make informed decisions about the optimal use of health technologies.

This page shows the most recent policy documents that mention this research output. Click here to find out how to access more activity.